Latest & greatest articles for gestational diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for gestational diabetes

81. Fasting Plasma Glucose at 24-28 Weeks to Screen for Gestational Diabetes Mellitus: New evidence from China

Fasting Plasma Glucose at 24-28 Weeks to Screen for Gestational Diabetes Mellitus: New evidence from China 23536582 2013 06 26 2014 02 03 2015 04 27 1935-5548 36 7 2013 Jul Diabetes care Diabetes Care Fasting plasma glucose at 24-28 weeks to screen for gestational diabetes mellitus: new evidence from China. 2038-40 10.2337/dc12-2465 To evaluate the usefulness of a fasting plasma glucose (FPG) at 24-28 weeks' gestation to screen for gestational diabetes mellitus (GDM). The medical records (...) Int J Gynaecol Obstet. 2011 Nov;115 Suppl 1:S30-3 22099438 Chin Med J (Engl). 2012 Apr;125(7):1212-3 22613589 Lancet. 2009 May 23;373(9677):1773-9 19465232 Diabetologia. 2007 Feb;50(2):298-306 17103140 JAMA. 1982 Aug 27;248(8):949-52 7097963 Diabetes Care. 2013 Sep;36(9):e166 23970737 Diabetes Care. 2013 Sep;36(9):e165 23970736 Diabetes Care. 2014 Feb;37(2):e34 24459163 Diabetes Care. 2014 Feb;37(2):e33 24459162 Blood Glucose metabolism China epidemiology Diabetes, Gestational blood epidemiology

EvidenceUpdates2013 Full Text: Link to full Text with Trip Pro

82. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin

Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin 23020608 2013 01 28 2013 08 02 2013 11 21 1463-1326 15 3 2013 Mar Diabetes, obesity & metabolism Diabetes Obes Metab Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. 246-51 10.1111/dom.12017 We compared metformin with insulin as treatment of gestational diabetes mellitus (GDM). Furthermore (...) the metformin and insulin groups. There were no significant differences in neonatal or maternal data between the groups. Only 23 (20.9%) of the 110 patients in the metformin group needed additional insulin. Compared with the patients on metformin only, those needing additional insulin were older (p = 0.04), their oral glucose tolerance test had been performed earlier and diabetes therapy started earlier in gestation (p = 0.01 and p = 0.004, respectively). The risk for additional insulin was 4.6-fold

EvidenceUpdates2013

83. Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria

Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria Gestational diabetes and pregnancy outcomes - a systematic review of the World Health (...) Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA, Duncan BB, Schmidt MI CRD summary This review evaluated the impact on pregnancy outcomes of using World Health Organisation (WHO) and/or International Association of the Diabetes in Pregnancy Study Group (IADPSG) criteria to diagnose gestational diabetes. Associations were similar when using each set of criteria

DARE.2013

84. Evaluation of the Value of Fasting Plasma Glucose in First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China

Evaluation of the Value of Fasting Plasma Glucose in First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China 23193214 2013 02 22 2013 09 04 2015 02 19 1935-5548 36 3 2013 Mar Diabetes care Diabetes Care Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china. 586-90 10.2337/dc12-1157 To evaluate the value of fasting plasma glucose (FPG) value in the first prenatal visit to diagnose gestational diabetes (...) mellitus (GDM). Medical records of 17,186 pregnant women attending prenatal clinics in 13 hospitals in China, including the Peking University First Hospital (PUFH), were examined. Patients with pre-GDM were excluded; data for FPG at the first prenatal visit and one-step GDM screening with 75-g oral glucose tolerance test (OGTT) performed between 24 and 28 weeks of gestation were collected and analyzed. The median ± SD FPG value was 4.58 ± 0.437. FPG decreased with increasing gestational age. FPG level

EvidenceUpdates2013 Full Text: Link to full Text with Trip Pro

85. Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective?

Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Werner EF (...) , Funai EF, Pettker CM, Henderson J, Zuckerwise L, Thung SF, Reel M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of criteria for the diagnosis of gestational diabetes mellitus, as proposed

NHS Economic Evaluation Database.2013

86. Randomised controlled trial: Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)?

Randomised controlled trial: Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? Article Text Therapeutics Randomised controlled trial Should metformin be preferred over insulin therapy in the management of gestational diabetes (GDM)? Shannon D Sullivan

Evidence-Based Medicine (Requires free registration)2013

87. Screening and diagnosing gestational diabetes mellitus

Screening and diagnosing gestational diabetes mellitus Screening and diagnosing gestational diabetes mellitus Screening and diagnosing gestational diabetes mellitus Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L Citation Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, Pasichnyk D, Seida JC, Donovan L. Screening and diagnosing gestational diabetes mellitus. Rockville: Agency for Healthcare Research and Quality (AHRQ (...) for offspring as a result of GDM and its treatment, and the "real world" effects of GDM treatment on use of care. Final publication URL Additional data URL Indexing Status Subject indexing assigned by CRD MeSH Diabetes, Gestational; Mass Screening; Pregnancy Complicationss Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence AHRQ, Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road

Health Technology Assessment (HTA) Database.2012

88. No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomised controlled trial

No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomised controlled trial 22616913 2012 07 11 2012 09 21 2012 07 11 1471-0528 119 9 2012 Aug BJOG : an international journal of obstetrics and gynaecology BJOG No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk (...) for gestational diabetes: results of a randomised controlled trial. 1098-107 10.1111/j.1471-0528.2012.03366.x To evaluate the effectiveness of an exercise programme for pregnant women who were overweight or obese and at risk for gestational diabetes mellitus (GDM). Randomised controlled trial. Hospitals and midwifery practices in the Netherlands. Pregnant women who were overweight or obese and at risk for GDM between 2007 and 2011. Normal care was compared with an exercise training programme during pregnancy

EvidenceUpdates2012

89. The usefulness of HbA1c in postpartum reclassification of gestational diabetes.

The usefulness of HbA1c in postpartum reclassification of gestational diabetes. 22530667 2012 05 10 2012 07 27 2015 11 19 1471-0528 119 7 2012 Jun BJOG : an international journal of obstetrics and gynaecology BJOG The usefulness of HbA1c in postpartum reclassification of gestational diabetes. 891-4 10.1111/j.1471-0528.2012.03325.x To investigate the role of HbA1c in postpartum reclassification of gestational diabetes (GDM) we studied 364 women with GDM attending the postpartum reclassification (...) i Virgili, Tarragona, Spain. amegia.hj23.ics@gencat.cat Näf S S Herranz L L Serrat N N Yañez R E RE Simón I I Vendrell J J eng Clinical Trial Journal Article Research Support, Non-U.S. Gov't 2012 04 24 England BJOG 100935741 1470-0328 0 Biomarkers 0 Hemoglobin A, Glycosylated 0 hemoglobin A1c protein, human AIM IM Adult Biomarkers blood Diabetes Mellitus, Type 2 blood diagnosis Diabetes, Gestational Female Hemoglobin A, Glycosylated metabolism Humans Pregnancy Prospective Studies Puerperal

EvidenceUpdates2012

90. Interventions for preventing gestational diabetes mellitus: A systematic review and meta-analysis

Interventions for preventing gestational diabetes mellitus: A systematic review and meta-analysis Interventions for preventing gestational diabetes mellitus: A systematic review and meta-analysis. Interventions for preventing gestational diabetes mellitus: A systematic review and meta-analysis. Oostdam N, van Poppel MN, Wouters MG, van Mechelen W CRD summary The authors concluded that there may have been some benefits of dietary counselling, low glycaemic dietary advice or an exercise programme (...) in preventing gestational diabetes mellitus in pregnant women, but no strong conclusions could be drawn from the evidence presented. The authors’ cautious conclusion accurately reflects the poor quality evidence presented and is likely to be reliable. Authors' objectives To evaluate the effects of interventions to prevent gestational diabetes mellitus. Searching PubMed, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from January 1980 to March 2011. Search terms were

DARE.2012

91. Treating mild gestational diabetes mellitus: a cost-effectiveness analysis

Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Treating mild gestational diabetes mellitus: a cost-effectiveness analysis Ohno MS, Sparks TN, Cheng YW, Caughey AB Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical (...) assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of treatment for mild gestational diabetes mellitus, from a societal perspective. The authors concluded that treatment for mild gestational diabetes improved both maternal and neonatal outcomes and was cost-effective. The cost-effectiveness framework was valid and the authors’ conclusions appear to be robust, but more detail on the data sources would have been useful. Type

NHS Economic Evaluation Database.2012

92. Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus

Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus 21977923 2011 12 13 2012 02 14 2011 12 13 1464-5491 29 1 2012 Jan Diabetic medicine : a journal of the British Diabetic Association Diabet. Med. Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus. 36-42 (...) 10.1111/j.1464-5491.2011.03473.x This study was performed to determine the effect of a single, large, intramuscular injection of vitamin D post-partum on glucose tolerance and insulin resistance in women with gestational diabetes. Forty-five participants in a randomized controlled trial on gestational diabetes mellitus were divided into an intervention group and a control group. Only subjects in the intervention group received one intramuscular injection of 300,000 IU of vitamin D3. HbA(1c), serum 25

EvidenceUpdates2012

93. Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment

Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment Falavigna M, Schmidt MI, Trujillo J, Alves LF, Wendland ER, Torloni MR, Colagiuri S, Duncan BB CRD summary This review concluded that gestational diabetes treatment compared to usual (...) antenatal care effectively reduced large for gestational age at birth, macrosomia, shoulder dystocia, pre-eclampsia and hypertensive disorders without compromising safety. The authors' conclusions reflect the evidence but the evidence base was small for some outcomes and the potential risk of bias in the included studies limits the reliability of the findings. Authors' objectives To assess the effectiveness of gestational diabetes treatment compared to usual antenatal care in the prevention of adverse

DARE.2012

94. Randomised controlled trial: Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes

Randomised controlled trial: Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Metformin is not significantly different from insulin for preventing fetal macrosomia in women with gestational diabetes Article Text Therapeutics Randomised controlled trial Metformin is not significantly different from insulin

Evidence-Based Medicine (Requires free registration)2012

95. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review

Glucose challenge test for detecting gestational diabetes mellitus: a systematic review Glucose challenge test for detecting gestational diabetes mellitus: a systematic review Glucose challenge test for detecting gestational diabetes mellitus: a systematic review van Leeuwen M, Louwerse MD, Opmeer BC, Limpens J, Serlie MJ, Reitsma JB, Mol BW CRD summary The authors concluded that higher accuracy measures were needed for the 50g glucose challenge test to be used as a definite diagnostic test (...) in place of the oral glucose tolerance test. This was a well-conducted review but limitations in the evidence available and potential for missing unpublished studies make the reliability and generalisability of the pooled results uncertain. Authors' objectives To determine the diagnostic accuracy of the 50g glucose challenge test for gestational diabetes mellitus. Searching MEDLINE and EMBASE were searched without methodological filter or other restrictions up to October 2010. Search terms were

DARE.2012

96. Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis

Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis Wahabi HA, Alzeidan RA, Esmaeil SA CRD summary The authors concluded that pre-pregnancy care in women with pre-gestational diabetes mellitus was effective in reducing rates (...) of congenital malformations, perinatal mortality and maternal glycated haemoglobin levels in the first trimester of pregnancy. This was generally a well-conducted review. The authors' conclusions regarding congenital malformations and perinatal mortality are likely to be reliable. Authors' objectives To assess the effectiveness and safety of pre-pregnancy care for improvements in rates of congenital malformation and perinatal mortality in women with pre-gestational diabetes mellitus. Searching MEDLINE

DARE.2012

97. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis

Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis Mission JF, Ohno MS, Cheng YW, Caughey AB Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study examined the cost-effectiveness of routine screening with the two-hour oral glucose tolerance test (OGTT) versus the one-hour glucose challenge test for gestational diabetes mellitus screening following new International Association of Diabetes in Pregnancy Study Group guidelines. The study used a valid cost-effectiveness framework and considered various

NHS Economic Evaluation Database.2012

99. Diabetes in Pregnancy and Gestational Diabetes Mellitus (GDM); Antidepressants in Pregnancy and Lactation

Diabetes in Pregnancy and Gestational Diabetes Mellitus (GDM); Antidepressants in Pregnancy and Lactation RxFiles Q&A Summary www.RxFiles.ca - April 2012 Lynette Kosar BSP, MSc Are Antidepressants Safe during Pregnancy & Breastfeeding? Up to ~25% of pregnant women will suffer from depression while pregnant. 1 The decision on how to treat depression and/or anxiety during & after pregnancy requires careful consideration of benefits and harms & collaborative discussions with the patient. SHOULD (...) and/or use other substances), and are less likely to take prenatal vitamins. ? There is a higher risk of spontaneous abortions, miscarriages, gestational hypertension, preeclampsia, preterm deliveries, low birth weight, small for gestational age, cesarean section, low Apgar scores, need for neonatal intensive care & ? length of hospital stay. - Some antidepressant studies have found these same risks, but most were unable to control for underlying depression. 1 ? Postpartum depression can impact

RxFiles2012

100. Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks` gestation)

Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks` gestation) 21930550 2011 10 03 2011 11 30 2011 10 03 1098-4275 128 4 2011 Oct Pediatrics Pediatrics Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks' gestation). e848-55 10.1542/peds.2010-3443 We hypothesized that maternal diabetes mellitus (DM) increases the risk for mortality, respiratory distress syndrome (RDS), and major complications of prematurity (...) . Analysis of prospectively collected (1995-2007) Israel National Very Low Birth Weight Infant Database. Maternal DM was recorded as pregestational or gestational. Multivariable logistic regression analysis was used to assess the independent effect of maternal DM status on infant mortality, RDS, and other complications of prematurity. Infants of mothers with pregestational (n = 120) and gestational (n = 825) DM were similar, and their data were pooled for analyses. Mothers with DM were more likely

EvidenceUpdates2011